GS
The Goldman Sachs Group, Inc.
GS has a slight edge over MET overall, supported by stronger fundamentals.
MET
MetLife, Inc.
MET has slightly lower modeled downside risk, despite its lower overall score.
GS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
GS's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like GS.
MET Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| N/A | |
| N/A |
MET's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MET.
GS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.6x | $528 | -42% |
| Current | 13x | $914 | — |
| Forward | 13x | $914 | — |
| Fair | 14x | $940 | +2.9% |
| Expensive | 17x | $1,214 | +33% |
Historical ranges are pointers, not guarantees.
GS has the edge over MET in the historical PE scenario, which offers more potential upside but is not a forecast.
MET PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8x | $61.38 | -40% |
| Forward | 9.4x | $102 | — |
| Current | 13x | $102 | — |
| Fair | 15x | $115 | +13% |
| Expensive | 25x | $191 | +88% |
Historical ranges are pointers, not guarantees.
MET's PE is in its fair range at 13x. If earnings grow as analysts expect, today's price would be 9.4x next year's earnings, in its cheap range.
GS Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for GS, with profitability improving. However, they disagree widely on these estimates.
MET Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect MET's earnings to grow and its profitability to improve, with its revenue holding steady.
GS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $72.35 | +4% |
| Q3 2026 | $69.58 | +41% |
| Q2 2026 | $64.82 | +43% |
| Q1 2026 | $54.75 | +27% |
| Q4 2025 | $51.32 | +27% |
| Q3 2025 | $49.22 | +44% |
| Q2 2025 | $45.37 | +45% |
| Q1 2025 | $43.08 | +68% |
| Q4 2024 | $40.54 | +77% |
GS has the edge over MET on earnings, with more consistent year-over-year improvement.
MET Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $10.87 | +42% |
| Q3 2026 | $7.68 | +45% |
| Q2 2026 | $5.23 | -11% |
| Q1 2026 | $5.17 | -16% |
| Q4 2025 | $4.71 | -21% |
| Q3 2025 | $5.28 | +6.5% |
| Q2 2025 | $5.87 | +58% |
| Q1 2025 | $6.12 | +110% |
| Q4 2024 | $5.94 | +225% |
MET earned $7.68 per share over the past year, up 45% from the year before.
GS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $18.7B | +23% |
| Q2 2026 | $20.3B | +39% |
| Q1 2026 | $17.2B | +14% |
| Q4 2025 | $13.5B | -3% |
| Q3 2025 | $15.2B | +20% |
| Q2 2025 | $14.6B | +15% |
| Q1 2025 | $15.1B | +6% |
| Q4 2024 | $13.9B | +23% |
GS has the edge over MET on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 37% | +2 points |
| Q2 2026 | 42% | +8.1 points |
| Q1 2026 | 38% | +0.2 points |
| Q4 2025 | 44% | +5.6 points |
| Q3 2025 | 36% | +4.1 points |
| Q2 2025 | 34% | +3.2 points |
| Q1 2025 | 37% | +0.6 points |
| Q4 2024 | 38% | +18 points |
GS has the edge over MET on profitability, with a higher operating margin.
MET Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.5B | +18% |
| Q2 2026 | $19.2B | +10% |
| Q1 2026 | $19.1B | +2.7% |
| Q4 2025 | $23.8B | +28% |
| Q3 2025 | $17.4B | -5.9% |
| Q2 2025 | $17.3B | -2.7% |
| Q1 2025 | $18.6B | +16% |
| Q4 2024 | $18.7B | -1.9% |
MET's revenue has grown year over year for four quarters in a row: $20.5B last quarter, up 18% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.9% | -0.6 points |
| Q2 2026 | 8.4% | +0.3 points |
| Q1 2026 | 8.6% | +0.9 points |
| Q4 2025 | 7% | -0.4 points |
| Q3 2025 | 9.5% | -1.3 points |
| Q2 2025 | 8% | +1.3 points |
| Q1 2025 | 7.6% | +1.1 points |
| Q4 2024 | 7.4% | +2.5 points |
MET's operating margin was 8.9% last quarter, down 0.6 points from the same quarter a year ago.
GS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +72% |
| Q2 2026 | $5.6B | +7.8% |
| Q1 2026 | -$32.4B | +$5.3B |
| Q4 2025 | -$16.8B | -136% |
| Q3 2025 | $2.1B | +$40.6B |
| Q2 2025 | $5.2B | -6.8% |
| Q1 2025 | -$37.7B | -$9.2B |
| Q4 2024 | $46.2B | +$75.1B |
GS's free cash flow was −$40B over the past year, against $15.8B the year before. Free cash flow isn't a meaningful measure for financial services companies like GS.
MET Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2B | -44% |
| Q2 2026 | $2.2B | +1.9% |
| Q1 2026 | $2.7B | -37% |
| Q4 2025 | $7.1B | +53% |
| Q3 2025 | $3.6B | -14% |
| Q2 2025 | $2.2B | -37% |
| Q1 2025 | $4.3B | +83% |
| Q4 2024 | $4.6B | -11% |
MET has the edge over GS on cash generation, producing positive trailing cash flow while its opponent burns cash.
GS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.2% | -3.8M shares |
| 1 year | -4.4% | -13.9M shares |
| 3 years | -12% | -42.8M shares |
| 5 years | -15% | -52.8M shares |
| Available history | -20% | -74.4M shares |
GS has 301M diluted shares, down 4.4% from a year ago, with $15B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3B |
| Q2 2026 | $4B |
| Q1 2026 | $5B |
| Q4 2025 | $3B |
| Q3 2025 | $2B |
| Q2 2025 | $3B |
| Q1 2025 | $4.4B |
| Q4 2024 | $2B |
GS spent $15B buying back its own shares over the past year, up 32% from the year before.
MET Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.1% | -7M shares |
| 1 year | -4.4% | -29.2M shares |
| 3 years | -15% | -116M shares |
| 5 years | -26% | -221M shares |
| Available history | -32% | -305M shares |
MET has 640M diluted shares, down 4.4% from a year ago, with $2.6B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $651M |
| Q2 2026 | $722M |
| Q1 2026 | $755M |
| Q4 2025 | $460M |
| Q3 2025 | $502M |
| Q2 2025 | $510M |
| Q1 2025 | $1.4B |
| Q4 2024 | $406M |
MET spent $2.6B buying back its own shares over the past year, down 8.5% from the year before.
GS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -5.4x | Net Cash |
| Q2 2026 | -6.1x | Net Cash |
| Q1 2026 | -6.7x | Net Cash |
| Q4 2025 | -6.4x | Net Cash |
| Q3 2025 | -3.5x | Net Cash |
| Q2 2025 | -3.1x | Net Cash |
| Q1 2025 | -3.9x | Net Cash |
| Q4 2024 | -4.7x | Net Cash |
GS has the edge over MET on leverage, with a lower net debt burden relative to earnings.
MET Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.1x | Net Cash |
| Q2 2026 | -2.0x | Net Cash |
| Q1 2026 | -2.6x | Net Cash |
| Q4 2025 | -2.8x | Net Cash |
| Q3 2025 | -2.6x | Net Cash |
| Q2 2025 | -2.7x | Net Cash |
| Q1 2025 | -2.7x | Net Cash |
| Q4 2024 | -3.3x | Net Cash |
MET has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like MET.
GS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.5 | Neutral |
| Stochastic | 16.3 | Oversold |
GS's weekly RSI is 45 (neutral) and its Stochastic is 16 (oversold).
MET Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 65.6 | Neutral |
| Stochastic | 58.9 | Neutral |
MET's weekly RSI is 66 (neutral) and its Stochastic is 59 (neutral).
GS PE vs Financial Services Sector
| Metric | GS | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 13x | 0.8% above |
| PE % | 46 | 63 | 17 pts below |
GS has the edge over MET on valuation relative to its sector.
MET PE vs Financial Services Sector
| Metric | MET | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 13x | 1.8% above |
| PE % | 41 | 63 | 22 pts below |
MET is trading at 13x earnings, in line with the Financial Services sector's median of 13x.
GS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $895.5 | 2% above |
| 20 week MA | $977.4 | 6.5% below |
| 50 week MA | $945.4 | 3.4% below |
| 100 week MA | $804.5 | 14% above |
| 200 week MA | $602.7 | 52% above |
GS's trend is mixed: it's above three of its five weekly moving averages, and 52% above its 200-week average.
MET Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $98.8 | 3.1% above |
| 20 week MA | $96.8 | 5.3% above |
| 50 week MA | $85.6 | 19% above |
| 100 week MA | $82.5 | 23% above |
| 200 week MA | $75.3 | 35% above |
MET has the edge over GS on trend strength, trading above more of its moving averages.
GS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $230.7 | $256.2 | +11% |
| 2021 | $256.2 | $385.0 | +50% |
| 2022 | $385.0 | $345.5 | -10% |
| 2023 | $345.5 | $385.8 | +12% |
| 2024 | $385.8 | $576.2 | +49% |
| 2025 | $576.2 | $907.0 | +57% |
| 2026 YTD | $907.0 | $913.6 | +0.7% |
GS has finished higher in five of the last six years, two of them by more than 50%. It's up 0.7% so far in 2026.
MET Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $50.8 | $46.3 | -8.9% |
| 2021 | $46.3 | $61.8 | +33% |
| 2022 | $61.8 | $72.3 | +17% |
| 2023 | $72.3 | $66.1 | -8.5% |
| 2024 | $66.1 | $82.3 | +24% |
| 2025 | $82.3 | $80.3 | -2.4% |
| 2026 YTD | $80.3 | $101.9 | +27% |
MET has the edge over GS on returns for 2026, with the stronger performance.